Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and commercializing therapies for...
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 1,100,000 shares, a growth of 16.6% from the March 31st total of 943,100 shares. Approximately 6.3% of the shares of the stock are short sold. Based […]
Biodexa’s worldwide rights of eRapa come with a $17m grant from CPRIT to support the asset into Phase III clinical trials.
Aadi Bioscience (NASDAQ:AADI – Get Free Report) and Statera Biopharma (NASDAQ:STAB – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings. Profitability This table compares Aadi Bioscience and […]
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 17,772 shares of the company’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $2.31, for a total value of $41,053.32. Following the completion of the sale, the chairman now directly owns 1,393,771 shares of […]